AzTrials
AzTrials

Healthy Adult ParticipantsAppleNMRNCT07499960

Apple Intake Effect on Faecal Metabolome

A study testing Apple consumption in people with Healthy Adult Participants, run by Czech University of Life Sciences Prague at 1 site in Czechia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This pilot dietary intervention study aimed to investigate whether short-term consumption of apples influences the human faecal metabolomic profile. Apples are a commonly consumed source of dietary fibre, particularly pectin, which undergoes microbial fermentation in the colon and may lead to measurable metabolic… Read more about this study

Who is it for?
Ages 18 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Adult Participants
What is being tested?
Apple consumption
Could I receive a placebo?
No, everyone receives an active treatment
How many people
15 participants
Where
1 siteCzechia
Study dates
1 Apr 2023to 25 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy adults aged 18-30 years
  • Able and willing to consume apples daily during the intervention period
  • Willing to provide stool samples before and after the intervention
  • Not following a specific prescribed diet
  • Physically able to maintain usual daily activities during the study
  • Able to provide written informed consent

Who cannot join

  • Diagnosed gastrointestinal, metabolic, or chronic systemic disease
  • Use of antibiotics, probiotics, or regular medication affecting digestion in the period prior to enrolment
  • Known allergy or intolerance to apples or other fruits
  • Current participation in another dietary or clinical study
  • Following a medically prescribed or restrictive diet
  • Pregnancy or breastfeeding

Trial locations and contacts

1 site in 1 country.

Czechia1 site
  • Czech University of Life Sciences Prague

    Prague, Prague, 16500

Other trials in Czechia

About this study

Official title: Impact of Short-term Apple Intake on the Human Faecal Metabolome Assessed by 1H NMR Spectroscopy

This pilot dietary intervention study aimed to investigate whether short-term consumption of apples influences the human faecal metabolomic profile. Apples are a commonly consumed source of dietary fibre, particularly pectin, which undergoes microbial fermentation in the colon and may lead to measurable metabolic changes. Healthy adult volunteers were instructed to consume three apples per day for three consecutive days under free-living conditions. Faecal samples were collected before and after the intervention and analysed using proton nuclear magnetic resonance (¹H NMR) spectroscopy to assess changes in metabolite concentrations. The study sought to explore whether metabolomic profiling can detect functional microbial responses to increased fruit intake and provide preliminary insight into the metabolic impact of short-term dietary fibre exposure.

Read the detailed description

This study was designed as a single-arm exploratory dietary intervention to evaluate short-term metabolic responses to increased intake of fruit-derived dietary fibre. Participants were instructed to consume three fresh Gala apples per day for three consecutive days while otherwise maintaining their habitual diet and lifestyle. The intervention was conducted under free-living conditions to reflect realistic dietary behaviour.

Faecal samples were collected immediately before the intervention and after completion of the three-day exposure period. Samples were processed using standardized laboratory protocols to obtain aqueous extracts suitable for metabolomic analysis. Proton nuclear magnetic resonance (¹H NMR) spectroscopy was employed to generate quantitative metabolic profiles, enabling detection of metabolites associated with microbial fermentation and host-microbe metabolic interactions.

Metabolite concentrations were quantified using targeted profiling approaches, and both multivariate and univariate statistical analyses were applied to assess intervention-related changes in the faecal metabolome. The study was intended to provide mechanistic insight into how short-term consumption of a commonly consumed fruit may influence gut microbial metabolic activity, and to evaluate the feasibility of metabolomics-based assessment of dietary exposures in small-scale human intervention studies.

Being tested
Apple consumption
Keywords
Apples, Dietary fiber, Pectin fermentation, Faecal metabolome, NMR

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Apple consumptionOther

    The intervention consisted of short-term added intake of fruit-derived dietary fibre through consumption of three whole apples daily over a three-day period. Participants were asked to maintain habitual dietary patterns apart from the prescribed apple consumption.

Study groups in NCT07499960
Study groupRoleWhat they receive
Apple Dietary InterventionExperimentalParticipants consumed three fresh apples per day for three consecutive days under free-living conditions while maintaining their habitual diet. Faecal samples were collected before and after the intervention to assess changes in metabolomic profiles.
Receives: Other: Apple consumption

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in faecal metabolomic profile assessed by ¹H NMR spectroscopy

    The outcome measure represents the change in concentrations of detected faecal metabolites between pre- and post-intervention samples, reflecting potential alterations in gut microbial metabolic activity associated with increased fruit intake.

    Measured: Baseline and immediately after completion of the 3-day dietary intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Mar 2026
  2. Study start1 Apr 2023
  3. Primary completion30 Aug 2024
  4. Study completion25 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Model description
The study followed a single-group pre-post intervention design. All participants were exposed to a standardized short-term dietary intervention consisting of daily apple consumption. Outcome assessment was based on paired analysis of pre-intervention and post-intervention faecal metabolomic profiles.
Masking
None (open label)
Enrolment
15 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07499960
Sponsor's protocol ID
EK/81/2023
Acronym
AppleNMR
Status last verified
Mar 2026
First submitted
24 Mar 2026
Last updated
1 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual-level participant data will not be publicly shared due to privacy considerations and ethical restrictions. De-identified summary data supporting the study findings may be available from the investigators upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Apple consumption in people with Healthy Adult Participants, run by Czech University of Life Sciences Prague at 1 site in Czechia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Czechia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in faecal metabolomic profile assessed by ¹H NMR spectroscopy (time frame: Baseline and immediately after completion of the 3-day dietary intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in